•  
  •  
  •  
  •  

2025-08-31 15:22:53

  • Home
  • Commodities
  • Industry News
  • IPO
  • Mutual Funds
  • Others
  • Research
  • Watch List
Latest News
  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism

Keywords Selected:  PreApprovalInspection

Stock Report

  • Granules India Ltd receives 1 observation from USFDA for Chantilly facility
  • Gland Pharma Ltd receives EIR from US FDA for JNPC Facility, Visakhapatnam
  • Piramal Pharma Limited's Ahmedabad facility successfully completes USFDA Pre-Approval Inspection
  • Torrent Pharmaceuticals Ltd gets Form 483 with 5 observations for Indrad facility
  • Piramal Pharma Ltd gets Form 483 with 2 observations from USFDA for Lexington, USA facility
  • Torrent Pharmaceuticals Ltd gets Form 483 from USFDA after Pre-Approval Inspection for Bileshwarpura facility
  • Bajaj Healthcare Ltd receives EIR from USFDA for API manufacturing facility in Savli
  • Aurobindo Pharma Ltd's Unit 7 completes USFDA PAI successfully
  • US FDA Inspection at Pashmylaram Facility, Hyderabad of Gland Pharma Ltd
  • Zydus Lifesciences Ltd gets 3 observations from USFDA for Pharmex, Ahmedabad facility
  • Bliss GVS Pharma Ltd gets 3 minor observations from USFDA for Palghar unit
  • USFDA Pre-Approval Inspection of Oral Oncology Manufacturing facility, Gujarat
  • Granules India Ltd gets 3 observations from USFDA for Gagillapur facility
  • Alembic Pharmaceuticals gets 5 observations from USFDA for Solid Oral Formulation Facility (F-4) at Jarod
  • Bajaj Healthcare Ltd announces successful completion of USFDA pre approval inspection at API facility
  • Syngene International Ltd update on USFDA Inspection of Biologics facility
  • Laurus Labs Ltd gets one observation from USFDA for Pre-Approval Inspection
  • Cipla Ltd receives EIR for Indore plant
  • US FDA inspection at Alkem's manufacturing facility located at St. Louis, USA
  • USFDA completes inspection at Aurolife Pharma LLC's Raleigh Unit
  • Casper Pharma completed USFDA pre-approval inspection
  • Biocon gets 3 observations from US FDA for Site 3 at Hyderabad
  • Dr. Reddy's Laboratories updates on PAI of formulations facility
  • Cipla updates on US FDA product-specific Pre-Approval Inspection

Latest Post

  • Titan unveils 8 new brand outlets across Delhi NCR, strengthening their retail footprint with 1000+ stores in FY26
  • Zigly Unveils New Experience Centre at Phoenix Marketcity, Strengthens Mumbai Presence
  • XTGlobal Infotech Ltd and ICICI Bank Ltd enter into loan agreement
  • NCC Limited receives orders worth Rs. 788.34 crore
  • Thomas Cook India & SOTC Travel ink long-term strategic MOU with Queensland Tourism


Announcement

To Advertise in our website please e-mail us at advertisement@equitybulls.com
Companies can send their Press Releases to pressrelease@equitybulls.com

Links

  • Home
  • Contact
  • Our Team

Contact

The website is developed and maintained by Chennai Scripts
C-4, Podhigai Flats, Pillayar Koil Street, Nesapakkam
Chennai
Tamil Nadu
India
600078
E-mail: chennaiscripts@gmail.com
Mobile Phone Number: +91-88776-69935
www.chennaiscripts.com

Website Created & Maintained by : Chennai Scripts
Nesapakkam, Chennai - 600 078,
Tamil Nadu, India

Disclaimer Copyright © - 2024